Clinical Trials Directory

Trials / Completed

CompletedNCT00209859

Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis

Combination Treatment With Methotrexate and Cyclosporine in Early Rheumatoid Arthritis.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
160 (planned)
Sponsor
Hvidovre University Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To investigate whether cyclosporine, added to methotrexate and steroid, increases the possibility of inflammatory management early in the disease; furthermore to investigate the possible steroid-sparing effect of cyclosporine in patients with recently diagnosed rheumatoid arthritis.

Detailed description

Design: Multicentre, prospective, randomised, double-blind study with parallel design. Selection of patients: Patients with recently diagnosed rheumatoid arthritis (less than 6 months of persistent synovitis).

Conditions

Interventions

TypeNameDescription
DRUGMethotrexate
DRUGIntraarticular betamethasone
DRUGCyclosporine/placebo-cyclosporine

Timeline

Start date
1998-10-01
Completion
2007-11-01
First posted
2005-09-21
Last updated
2005-09-21

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00209859. Inclusion in this directory is not an endorsement.

Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis (NCT00209859) · Clinical Trials Directory